Joanna Zurko

Assistant Professor of Hematology/BMT

University of Wisconsin-Madison

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Joanna Zurko is an Assistant Professor of Hematology/BMT at the University of Wisconsin–Madison. Her research focuses on CAR-T cell therapy, including its practice patterns, outcomes, and associated complications in the context of B-cell malignancies. Dr. Zurko's recent publications highlight her expertise in critical appraisal skills, hematopoietic cell transplantation, and the implications of immunotherapy in lymphomas.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Aniko Szabo

UNITED STATES

View details

Geoffrey Shouse

Assistant Clinical Professor

City Of Hope National Medical Center

UNITED STATES

View details

Ishan Roy

Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES

View details

Ryan Kraemer

The University of Alabama

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joanna Zurko

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

Association of a Gamified Journal Club on Internal Medicine Residents’ Engagement and Critical Appraisal Skills

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.

Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma.

Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome.

Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.

Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?

PD-1 blockade after bispecific LV20.19 CAR-T modulates CAR T-cell immunophenotype without meaningful clinical response.

Collaborators (4)

Aniko Szabo

Geoffrey Shouse

Ishan Roy

Ryan Kraemer

Make your next move.